
无数据
无数据
无数据
| CAS Number | 89-57-6 |
| Catalog Number | AG003MEP(AGN-PC-07Y4PB) |
| Chemical Name | 5-Amino-2-hydroxybenzoic acid |
| EC Number | 201-919-1 |
| IUPAC Name | 5-amino-2-hydroxybenzoic acid |
| InChI | InChI=1S/C7H7NO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,8H2,(H,10,11) |
| InChI Key | KBOPZPXVLCULAV-UHFFFAOYSA-N |
| MDL Number | MFCD00007877 |
| Molecular Formula | C7H7NO3 |
| Molecular Weight | 153.1354 |
| SMILES | C1=C(N)C=CC(=C1C(O)=O)O |
| UNII | 4Q81I59GXC |
| Synonyms | 5 Aminosalicylate,
5 Aminosalicylic Acid,
5-Aminosalicylate,
5-Aminosalicylic Acid,
Asacol,
Asacolon,
Ascolitin,
Canasa,
Claversal,
Fivasa,
Hydrochloride, Mesalamine,
Lixacol,
m Aminosalicylic Acid,
m-Aminosalicylic Acid,
Mesalamine,
Mesalamine Hydrochloride,
Mesalamine Monosodium Salt,
Mesalazine,
Mesasal,
meta Aminosalicylic Acid,
meta-Aminosalicylic Acid,
Monosodium Salt, Mesalamine,
Novo 5 ASA,
Novo-5 ASA,
Pentasa,
Rowasa,
Salofalk,
5-Aminosalicylic acid,
mesalamine,
Mesalazine,
89-57-6,
5-Amino-2-hydroxybenzoic acid,
Pentasa,
Claversal,
Asacol,
Canasa,
5-ASA,
Salofalk,
Rowasa,
m-Aminosalicylic acid,
Mesasal,
Lialda,
Fisalamine,
Lixacol,
Apriso,
Benzoic acid, 5-amino-2-hydroxy-,
5-Aminosalicylate,
p-Aminosalicylsaeure,
Asacolitin,
Mesalazina,
Mesalazinum,
sfRowasa,
5-amino-2-hydroxy-benzoic acid,
Asacol HD,
Mesalazinum [Latin],
5-Amino Salicylic Acid,
Mesalamine [USAN],
Mesalazina [Spanish],
p-Aminosalicylsaeure [German],
2-Hydroxy-5-aminobenzoic acid,
3-carboxy-4-hydroxyaniline,
SALICYLIC ACID, 5-AMINO-,
UNII-4Q81I59GXC,
MFCD00007877,
NSC 38877,
5-AS,
CCRIS 7334,
EINECS 201-919-1,
BRN 2090421,
AI3-15564,
MLS001424012,
4Q81I59GXC,
CHEBI:6775,
5-Aminosalicylic Acid, Purified,
KBOPZPXVLCULAV-UHFFFAOYSA-N,
mesalamine (USAN),
CAS-89-57-6,
NCGC00016344-03,
SMR000145728,
DSSTox_CID_4506,
DSSTox_RID_77435,
DSSTox_GSID_24506,
5-Aminosalicylic acid, 99%,
Mesavancol,
Delzicol,
Mesavance,
Mezavant,
Iialda,
Mesalazine MMX,
Mezavant XL,
Mesalamine (USP),
Pentasa (TN),
5-Aminosalicylicacid,
Salofalk Granu-Stix,
Apriso (TN),
Asacol (TN),
Canasa (TN),
Lialda (TN),
Rowasa (TN),
meta-Aminosalicylic Acid,
Mesalazine (JAN/INN),
SR-01000763486,
Mesalamine [USAN:USP],
HSDB 7512,
AJG-501,
MAX-002,
SPD 476,
SPD-476,
SPD-480,
Mesalamine (TN),
Mesalamine(Lialda),
Delzicol (TN),
Sfrowasa (TN),
Mesalazine [INN],
Mesalamine (Lialda),
MD-0901,
5-Aminosalicyclic acid,
5-amino-salicylic acid,
PubChem17623,
Mesalamine|||Mesalazine,
ACMC-1BKFR,
AC1L1HCS,
Prestwick0_001069,
Prestwick1_001069,
Prestwick2_001069,
Prestwick3_001069,
WLN: ZR DQ CVQ,
Z-206,
CHEMBL704,
EC 201-919-1,
cid_4075,
Oprea1_847633,
SCHEMBL31297,
3amino-6-hydroxybenzoic acid,
5-amino-2-hydroxybenzoicacid,
BSPBio_001058,
KBioGR_002425,
KBioSS_002431,
4-14-00-02058 (Beilstein Handbook Reference),
KSC448C0L,
MLS000758287,
5-Aminosalicylic acid, 95%,
5-Aminosalicylic acid, tablet,
ARONIS23914,
BIDD:GT0811,
3-amino-6-hydroxybenzoic acid,
SPBio_002969,
AC1Q51L9,
BPBio1_001164,
GTPL2700,
ZINC1688,
5-Amino 2-hydroxy benzoic acid,
DTXSID5024506,
SCHEMBL18038934,
5-Aminosalicylic acid, >=99%,
BDBM60918,
CTK3E8105,
KBio2_002425,
KBio2_004993,
KBio2_007561,
KBio3_002904,
cMAP_000045,
HMS1571E20,
HMS2051M21,
HMS2090I09,
HMS2098E20,
HMS3393M21,
HMS3649K15,
HMS3651M15,
HMS3715E20,
Pharmakon1600-01505993,
BCP05326,
KS-00000CC5,
KS-000048PQ,
NSC38877,
Tox21_110384,
Tox21_201610,
Tox21_303125,
5-?Aminosalicylic Acid (Mesalazine),
5-Amino-2-hydroxybenzoic acid 97%,
AN-874,
ANW-39326,
BBL013046,
FC1035,
NSC-38877,
NSC759301,
s1681,
SBB052617,
STK301678,
AKOS000118959,
Tox21_110384_1,
AC-2764,
BCP9000175,
CCG-100829,
CS-2219,
DB00244,
HS-0100,
LS-1894,
LS11426,
MCULE-5752745805,
NC00079,
NSC-759301,
RP21708,
RTR-032941,
TRA0073805,
NCGC00016344-01,
NCGC00016344-02,
NCGC00016344-04,
NCGC00016344-05,
NCGC00016344-07,
NCGC00090934-01,
NCGC00090934-02,
NCGC00257142-01,
NCGC00259159-01,
AJ-08068,
AK-72925,
BP-13074,
BR-72925,
CPD000145728,
HY-15027,
SAM001247020,
SC-15695,
SY002854,
5-Aminosalicylic acid, analytical standard,
AB1001921,
ST2411704,
ST4109571,
TR-032941,
A0317,
AB00374979,
AM20060091,
FT-0619950,
SW197303-4,
MFCD00007877 (98%),
1764-EP2272825A2,
1764-EP2275420A1,
C07138,
D00377,
M-7246,
24215-EP2289518A1,
24215-EP2295053A1,
24215-EP2295409A1,
24215-EP2314574A1,
24215-EP2314590A1,
90701-EP2371811A2,
AB00374979-09,
AB00374979-10,
AB00374979_11,
AB00374979_12,
5-amino-2-hydroxybenzoic acid,5-Aminosalicylic acid,
I06-0488,
Q-201355,
SR-01000763486-3,
SR-01000763486-4,
SR-01000763486-9,
Z57127471,
F1918-0003,
5-Amino-2-hydroxybenzoic acid; 5-AS; Mesalamine; 5-ASA,
A3613/0153179,
Mesalazine, European Pharmacopoeia (EP) Reference Standard,
Mesalamine, United States Pharmacopeia (USP) Reference Standard,
Mesalamine, Pharmaceutical Secondary Standard; Certified Reference Material,
InChI=1/C7H7NO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,8H2,(H,10,11,
Mesalazine for system suitability, European Pharmacopoeia (EP) Reference Standard,
Pentacol,
Asacolon,
Ascolitin,
Mesacol,
Fivasa,
mesalsal,
Salozinal,
Asalit,
Ipocol,
5 Aminosalicylate,
Mesalamine HCl,
minosalicylic acid,
5-aminosalicylsyre,
Aminosalicylic acid,
Mesalamine Hydrochloride,
m Aminosalicylic Acid,
Salofalk (TN),
5 Aminosalicylic Acid,
Mesalazina[Spanish],
Masacol (TN),
Novo 5 ASA,
Novo-5 ASA,
Iialda (TN),
Ipocal (TN),
Novo5 ASA,
meta Aminosalicylic Acid,
Hydrochloride, Mesalamine,
Meta-AminosalicylicAcid,
Mesalamine Monosodium Salt,
Byk Brand of Mesalamine,
Monosodium Salt, Mesalamine,
Falk Brand of Mesalamine,
Axcan Brand of Mesalamine,
C7H7NO3,
5-amino-2-hydroxybenzoate,
D0C4YC,
Solvay Brand of Mesalamine,
Allphar Brand of Mesalamine,
Antigen Brand of Mesalamine,
Farmasa Brand of Mesalamine,
Ferring Brand of Mesalamine,
Merckle Brand of Mesalamine,
Norgine Brand of Mesalamine,
Celltech Brand of Mesalamine,
Provalis Brand of Mesalamine,
Novopharm Brand of Mesalamine,
SmithKline Brand of Mesalamine,
Yamanouchi Brand of Mesalamine,
CID4075,
Salicylic acid, 5-amino-(8CI),
C7-H7-N-O3,
Henning Berlin Brand of Mesalamine,
ACN-S002469,
GlaxoSmithKline Brand of Mesalamine,
Schering Plough Brand of Mesalamine,
Schering-Plough Brand of Mesalamine,
Procter & Gamble Brand of Mesalamine,
Sanofi Synthelabo Brand of Mesalamine,
CS-O-05654,
CS-O-10279,
A2291,
B1969,
D019804,
5-Aminosalicylic acid, 98.5%, an NF-kB and PGDH inhibitor - 500G 500g,
5-aminosalicylic acid, Mesalazine, Asacol, Pentasa, Canasa, Mesalamine,
51481-17-5,
6291-36-7,
m-A,
|
| Complexity | 160 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 153.043g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 11 |
| Hydrogen Bond Acceptor Count | 4 |
| Hydrogen Bond Donor Count | 3 |
| Isotope Atom Count | 0 |
| Molecular Weight | 153.137g/mol |
| Monoisotopic Mass | 153.043g/mol |
| Rotatable Bond Count | 1 |
| Topological Polar Surface Area | 83.6A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 1.3 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H315-H319-H335 |
| Packing Group | |
| Precautionary statements | P305+P351+P338-P261-P264-P280-P302+P352+P332+P313+P362+P364-P305+P351+P338+P337+P313-P280a-P304+P340-P405-P501a |
| UN Code |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

